Difficulty: Medium
Average Score: 67%
Practice
The drug acts by competing with aldosterone for its cytosolic receptors:
Correct answer
D
Rationale
Step-by-step rationale for why D (Spironolactone) is correct:
1. Spironolactone is an aldosterone receptor antagonist.
2. By competing with aldosterone for its cytosolic receptors, spironolactone inhibits its action.
3. This leads to decreased sodium reabsorption and potassium retention.
4. Spironolactone is used in conditions like heart failure, hypertension, and hyperaldosteronism.
Summary of why other choices are incorrect:
- A (Acetazolamide): Acts as a carbonic anhydrase inhibitor.
- B (Furosemide): Inhibits the Na+/K+/2Cl- cotransporter in the loop of Henle.
- C (Hydrochlorothiazide): Inhibits sodium reabsorption in the distal convoluted tubule by blocking the Na+/Cl- cotransporter.
1. Spironolactone is an aldosterone receptor antagonist.
2. By competing with aldosterone for its cytosolic receptors, spironolactone inhibits its action.
3. This leads to decreased sodium reabsorption and potassium retention.
4. Spironolactone is used in conditions like heart failure, hypertension, and hyperaldosteronism.
Summary of why other choices are incorrect:
- A (Acetazolamide): Acts as a carbonic anhydrase inhibitor.
- B (Furosemide): Inhibits the Na+/K+/2Cl- cotransporter in the loop of Henle.
- C (Hydrochlorothiazide): Inhibits sodium reabsorption in the distal convoluted tubule by blocking the Na+/Cl- cotransporter.